U.S. Senate · 119th Congress · S. 1818
Prescription Drug Price Relief Act of 2025
A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Bernard SandersD-VT
- Introduced
- May 20, 2025, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (7)
7 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Richard BlumenthalD-CT
- Cory A. BookerD-NJ
- Jeff MerkleyD-OR
- Christopher MurphyD-CT
- Elizabeth WarrenD-MA
- Peter WelchD-VT
Signed on later
- Sheldon WhitehouseD-RIJune 17, 2025